Asia’s biopharmaceutical industry has evolved from a manufacturing destination to a goto market for clinical development and a hotbed of innovation. Asia contains some of the world’s leading pharma and biopharma markets on the planet.
In response to this ongoing trend, SeerPharma sponsored and exhibited at BioPharma Asia from the 21st – 23rd March at the Suntec Convention Centre in Singapore.
With over 1500 delegates across the Asia-Pac region present, we were inundated with requests for assistance on bringing new biopharmaceutical products to market. Delegates were keen for advice on matters of Quality Assurance and GMP compliance to relevant FDA and PIC/S guidelines and a number of requests have been made for assistance with new facilities and with the upskilling of staff in this burgeoning sector.
As Asia-Pacific’s leader in QA and GMP Solutions, SeerPharma is proud to support and assist the industry.
This post comes from our April 2017 Journal. You may also be interested in:
- SeerPharma Symposium
- 3 Key Quality / GMP Topics at the ARCS Congress
- SeerPharma sponsors BioMelbourne “Corporate Culture and Risk” session
- International Regulatory Convergence for MTP GMP